BMF - Bcl2 modifying factor Gene

Species: Sus scrofa

Gene Type: protein coding
Gene ID: 110261428

BMF Products (16)

mRNA Protein Name
XM_021097837.1 XP_020953496.1 bcl-2-modifying factor isoform X3
XM_021097833.1 XP_020953492.1 bcl-2-modifying factor isoform X2
XM_021097841.1 XP_020953500.1 bcl-2-modifying factor isoform X3
XM_021097855.1 XP_020953514.1 bcl-2-modifying factor isoform X5
XM_021097846.1 XP_020953505.1 bcl-2-modifying factor isoform X3
XM_021097854.1 XP_020953513.1 bcl-2-modifying factor isoform X5
XM_021097831.1 XP_020953490.1 bcl-2-modifying factor isoform X1
XM_021097848.1 XP_020953507.1 bcl-2-modifying factor isoform X3
XM_021097840.1 XP_020953499.1 bcl-2-modifying factor isoform X3
XM_021097853.1 XP_020953512.1 bcl-2-modifying factor isoform X5
XM_021097847.1 XP_020953506.1 bcl-2-modifying factor isoform X3
XM_021097857.1 XP_020953516.1 bcl-2-modifying factor isoform X5
XM_021097851.1 XP_020953510.1 bcl-2-modifying factor isoform X4
XM_021097829.1 XP_020953488.1 bcl-2-modifying factor isoform X1
XM_021097842.1 XP_020953501.1 bcl-2-modifying factor isoform X3
XM_021097844.1 XP_020953503.1 bcl-2-modifying factor isoform X3
Protein Preferred Names Protein Names

bcl-2-modifying factor

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Phase
HY-150105 Icovamenib Inhibitor 98.96% Phase 2
HY-50868 Bafetinib 99.18% Phase 2

Pre-clinical Phase

Bioactive Molecules (5)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-147135 MYF-03-69 98.11% Unkown
HY-P1733 BMf-BH3 / Unkown
HY-RS01531 BMF Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS18018 Bmf Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS24491 Bmf Rat Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens BMF NCBI NCBI:90427